huperzine A chelated
Selected indexed studies
- Huperzine-A Improved Animal Behavior in Cuprizone-Induced Mouse Model by Alleviating Demyelination and Neuroinflammation. (Int J Mol Sci, 2022) [PMID:36555825]
- Molecular modeling of multi-target analogs of huperzine A and applications in Alzheimer's disease. (J Mol Model, 2024) [PMID:38850372]
- Bivalent ligands derived from Huperzine A as acetylcholinesterase inhibitors. (Curr Top Med Chem, 2007) [PMID:17305579]
_Worker-drafted node — pending editorial review._
Connections
huperzine A chelated helps
huperzine A chelated protects against
Sources
- Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. (2010) pubmed
- Management of oxidative stress and other pathologies in Alzheimer's disease. (2019) pubmed
- Huperzine-A Improved Animal Behavior in Cuprizone-Induced Mouse Model by Alleviating Demyelination and Neuroinflammation. (2022) pubmed
- Molecular modeling of multi-target analogs of huperzine A and applications in Alzheimer's disease. (2024) pubmed
- Bivalent ligands derived from Huperzine A as acetylcholinesterase inhibitors. (2007) pubmed
- Huperzine A, reduces brain iron overload and alleviates cognitive deficit in mice exposed to chronic intermittent hypoxia. (2020) pubmed
- Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease. (2018) pubmed
- Donepezil, a drug for Alzheimer's disease, promotes oligodendrocyte generation and remyelination. (2019) pubmed
- Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy. (2016) pubmed